Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 6

Molecular and presymptomatic analysis of a Moroccan Lynch syndrome family revealed a novel frameshift MLH1 germline mutation

Pages
701–704
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The outcome of the present case suggests that this mutationwas the primary cause of LS in the family

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lynch syndrome (LS) is an autosomal dominant disorder characterized by an increased risk of extracolonic cancers and early age ofonset.
📊
Key Findings & Data:The proband is a 64-year-old womandiagnosed with a tumor of the cecum.
💡
Conclusion & Impact:The outcome of the present case suggests that this mutationwas the primary cause of LS in the family
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Lynch syndrome (LS) is an autosomal dominant disorder characterized by an increased risk of extracolonic cancers and early age ofonset. It is associated with germline mutations in the DNA mismatch repair (MMR) genes. We report a case of a patient with colorectalcancer referred to our medical genetics department for molecular analysis and genetic counseling. The proband is a 64-year-old womandiagnosed with a tumor of the cecum. Histopathological examination showed a moderately differentiated mucinous adenocarcinomacategorized by pT3 N0. Analysis of her pedigree revealed three siblings who had colon cancer, as well as one relative with brain cancer.Based on these findings, molecular genetic investigation was found to be necessary in order to identify the disease-causing mutation.Immunohistochemistry staining of MMR proteins was performed on the tumor sample of the index proband. Mutational analysis of theMLH1/MSH2 genes was carried out. Analysis was extended to the family members and the general population. This led to the identification of a heterozygous frameshift duplication in the MLH1 gene at position 910 (c.910dupG). Three siblings had inherited the mutationfrom their mother, two of whom were asymptomatic at the time of diagnosis. To the best of our knowledge, this is a novel pathogenicduplication that has not been reported in the databases and literature. The outcome of the present case suggests that this mutationwas the primary cause of LS in the family

🔖

Cite This Article

MOUFID, F. Z., BOUGUENOUCH, L., BOUCHİKHİ, I. E., HOUSSAINI, M. I., OULDIM, K. (2018). Molecular and presymptomatic analysis of a Moroccan Lynch syndrome family revealed a novel frameshift MLH1 germline mutation. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 6, 701–704. https://ajindex.com/articles/410132

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006; 14: 390-402. [CrossRef] Müller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002; 20: 102-109. [CrossRef] Lung MS, Trainer AH, Campbell I, Lipton L. Familial colorectal cancer. Intern Med J 2015; 45: 482491. [CrossRef] Tiwari AK, Roy HK, Lynch HT. Lynch syndrome in the 21st century: clinical perspectives. QJM Mon J Assoc Physicians 2016; 109: 151-8. [CrossRef] Tutlewska K, Lubinski J, Kurzawski G. Germline deletions in the EPCAM gene as a cause of Lynch syndrome-literature review. Hered Cancer Clin Pract 2013; 11: 9. [CrossRef] Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 2014; 109: 1159-79. [CrossRef] Tomita N, Yamano T, Matsubara N, Tamura K: [A novel genetic disorder of Lynch syndrome - EPCAM gene deletion]. Gan To Kagaku Ryoho 2013; 40: 143-7.
  2. Bavi P, Uddin S, Bu R, et al. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL). J Pathol 2011; 224: 355-66. [CrossRef] Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215. [CrossRef] Zahary MN, Kaur G, Abu Hassan MR, Singh H, Naik VR, Ankathil R. Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients. World J Gastroenterol 2012; 18: 814-20. [CrossRef] Peltomäki P. Update on Lynch syndrome genomics. Fam Cancer 2016; 15: 385-93. [CrossRef] Ponti G, Castellsagué E, Ruini C, Percesepe A, Tomasi A. Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. Clin Genet 2015; 87: 507-16. [CrossRef] Montera M, Resta N, Simone C, et al. Mutational germline analysis of hMSH2 and hMLH1 genes in early onset colorectal cancer patients. J Med Genet 2000; 37: e7. [CrossRef] Limburg PJ, Harmsen WS, Chen HH, et al. DNA Mismatch Repair Gene Alterations in a Population-Based Sample of Young-Onset Colorectal Cancer Patients. Clin Gastroenterol Hepatol 2011; 9: 497- 502. [CrossRef]